These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 3891282)
41. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae. Cooper CE; Slocombe B; White AR J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699 [TBL] [Abstract][Full Text] [Related]
42. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. Schaad UB; Casey PA; Cooper DL Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187 [TBL] [Abstract][Full Text] [Related]
44. Comparative study of cephradine and amoxicillin-clavulanate in the treatment of recurrent urinary tract infections. Brumfitt W; Hamilton-Miller JM Antimicrob Agents Chemother; 1990 Sep; 34(9):1803-5. PubMed ID: 2285294 [TBL] [Abstract][Full Text] [Related]
45. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]. Miyachi Y; Ueda S; Hayakawa F; Nakashima T; Hakamada S; Kuno K Jpn J Antibiot; 1985 Feb; 38(2):423-30. PubMed ID: 4009951 [TBL] [Abstract][Full Text] [Related]
46. Differential sensitivities to amoxycillin/clavulanate and amoxycillin in general practice urinary infections. Brumfitt W; Hamilton-Miller JM Lancet; 1983 Sep; 2(8349):566. PubMed ID: 6136712 [No Abstract] [Full Text] [Related]
47. [Laboratory and clinical studies on BRL 25000 (clavulanic acid -amoxicillin) granules in the pediatric field]. Cho K; Sakata H; Fujita K; Yoshioka H; Mukai N Jpn J Antibiot; 1985 Feb; 38(2):253-62. PubMed ID: 4009947 [TBL] [Abstract][Full Text] [Related]
49. Activities of amoxicillin and clavulanic acid combinations against urinary tract infections. Crokaert F; van der Linden MP; Yourassowsky E Antimicrob Agents Chemother; 1982 Aug; 22(2):346-9. PubMed ID: 6765418 [TBL] [Abstract][Full Text] [Related]
50. Treatment of gonorrhea with clavulanate-potentiated amoxicillin (Augmentin). Munday PE; Bingham JS; Ison CA; Erdman YJ; Harris JR; Easmon CS Sex Transm Dis; 1985; 12(3):163-5. PubMed ID: 3929409 [TBL] [Abstract][Full Text] [Related]
51. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase]. Prát V; Horcicková M; Hatala M; Liska M; Matousovic K Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692 [No Abstract] [Full Text] [Related]
52. [Antimicrobial activities of clavulanic acid/amoxicillin against freshly isolated clinical strains from outpatients]. Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T Jpn J Antibiot; 1995 Dec; 48(12):1920-34. PubMed ID: 8587166 [TBL] [Abstract][Full Text] [Related]
53. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]. Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521 [TBL] [Abstract][Full Text] [Related]
54. Amoxycillin clavulanate: an assessment after 15 years of clinical application. Ball P; Geddes A; Rolinson G J Chemother; 1997 Jun; 9(3):167-98. PubMed ID: 9210001 [No Abstract] [Full Text] [Related]
55. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]. Sunakawa K; Ishizuka Y Jpn J Antibiot; 1985 Feb; 38(2):319-26. PubMed ID: 3892075 [TBL] [Abstract][Full Text] [Related]
56. [The development of bacterial resistance and the role of clavulanic acid]. Rolinson JN Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658 [No Abstract] [Full Text] [Related]